Accelerating
therapies for
aging and its
diseases.Accelerating therapies for aging and its diseases.
therapies for
aging and its
diseases.Accelerating therapies for aging and its diseases.
A team of scientists, engineers, and drug developers working together to increase healthy lifespan and dramatically reduce disease.
Mission
An opportunity to dramatically reduce disease.
By targeting the biological processes of aging itself, we aim to develop new therapies for the diseases of old age — from cardiovascular to neurodegenerative disease — and increase our healthy lifespans.
Advancing a pipeline of aging therapies, faster.
Our approach
Accelerating discovery with machine learning.
Several lines of research recently bolstered the belief that by understanding and treating the damage that accumulates in our bodies as we age, we will be able to slow or repair this damage with dramatic benefits for our health and lifespan.
The most studied lines of evidence for this claim are focused on the fields of senescence, caloric restriction, parabiosis, and even the use of existing drugs like Metformin. We can reproducibly use these fields to increase the lifespan of animals while delaying onset of multiple diseases — and this evidence has been built by world-class scientists at UCSF, Stanford, and more of the world's best labs.
While aging research holds enormous promise, it takes far too long to run experiments and translate their findings into the clinic. This significantly slows down the search for therapies that could one day reduce cardiovascular disease, neurodegenerative diseases, and more.
We've built a machine learning platform to accelerate the discovery of therapies and their advancement into the clinic, combining assay and drug development with a novel computational approach to tackle one of the world's most important problems: battling aging and its diseases.Several lines of research recently bolstered the belief that by understanding and treating the damage that accumulates in our bodies as we age, we will be able to slow or repair this damage with dramatic benefits for our health and lifespan.
We've built a machine learning platform to accelerate the discovery of such therapies and their advancement into the clinic, combining assay and drug development with a novel computational approach to tackle one of the world's most important problems: battling aging and its diseases.
The most studied lines of evidence for this claim are focused on the fields of senescence, caloric restriction, parabiosis, and even the use of existing drugs like Metformin. We can reproducibly use these fields to increase the lifespan of animals while delaying onset of multiple diseases — and this evidence has been built by world-class scientists at UCSF, Stanford, and more of the world's best labs.
While aging research holds enormous promise, it takes far too long to run experiments and translate their findings into the clinic. This significantly slows down the search for therapies that could one day reduce cardiovascular disease, neurodegenerative diseases, and more.
We've built a machine learning platform to accelerate the discovery of therapies and their advancement into the clinic, combining assay and drug development with a novel computational approach to tackle one of the world's most important problems: battling aging and its diseases.Several lines of research recently bolstered the belief that by understanding and treating the damage that accumulates in our bodies as we age, we will be able to slow or repair this damage with dramatic benefits for our health and lifespan.
We've built a machine learning platform to accelerate the discovery of such therapies and their advancement into the clinic, combining assay and drug development with a novel computational approach to tackle one of the world's most important problems: battling aging and its diseases.
Investors
Sam Altman
© 2022 Spring Discovery. All rights reserved.
© 2022 Spring Discovery.All rights reserved.